Health care workers of color are nearly 2 times more likely than their white colleagues to test positive for coronavirus disease 2019; Teladoc Health announced an agreement to acquire Livongo, a diabetes coaching company, for $18.5 billion; the CDC has issued a warning against ingesting alcohol-based hand sanitizer in response to reports of poisonings in the United States.
According to a study by Harvard Medical School and published in The Lancet Public Health, health care workers of color were more likely to care for patients with suspected or confirmed coronavirus disease 2019 (COVID-19), more likely to report inadequate personal protective equipment, and nearly twice as likely as their white colleagues to test positive for COVID-19. Reported by Kaiser Health News, the study also found that health workers are at least 3 times more likely than the general population to report positive COVID-19 results, with health care workers of color having a 5 times greater risk of infection.
Yesterday, telemedicine provider Teladoc Health announced an agreement to acquire Livongo, a diabetes coaching company for $18.5 billion, according to STAT. The merger agreement was indicated to put the combined company on track to bring in $1.3 billion, potentially creating the first health tech giant. Amid the pandemic, stocks for both companies have reached all time highs this week. Compared with the start of 2020, Livongo’s share price is nearly 6 times higher and Teladoc’s is 3 times higher.
The CDC issued a warning yesterday against the ingestion of alcohol-based hand sanitizer in response to reports of poisonings in the United States. As detailed by The Hill, there were 15 reports issued by poison centers in Arizona and New Mexico of methanol poisoning associated with swallowing hand sanitizer between May and June. Of those who were hospitalized, 4 died and 3 were discharged with visual impairment. After a consumer alert on hand sanitizers containing methanol, the CDC received the case reports, which were all tied to those containing the toxic substance.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More